Amalgamated Bank Arrowhead Pharmaceuticals, Inc. Transaction History

Amalgamated Bank

$11.7 Billion
Q1 2024

A detailed history of Amalgamated Bank transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 64,664 shares of ARWR stock, worth $1.62 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

64,664

Previous 66,641 2.97%

Holding current value

$1.62 Million

Previous $2.04 Million 9.32%

% of portfolio

0.02%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$27.21 - $39.48 $53,794 - $78,051	-1,977 Reduced 2.97%	64,664 $1.85 Million
Q4 2023 Feb 06, 2024	BUY	$21.2 - $31.03 $2,607 - $3,816	123 Added 0.18%	66,641 $2.04 Million
Q3 2023 Nov 08, 2023	SELL	$26.2 - $36.08 $71,709 - $98,750	-2,737 Reduced 3.95%	66,518 $1.79 Million
Q2 2023 Aug 11, 2023	SELL	$25.16 - $41.38 $61,516 - $101,174	-2,445 Reduced 3.41%	69,255 $2.47 Million
Q1 2023 May 02, 2023	SELL	$23.68 - $38.51 $63,651 - $103,514	-2,688 Reduced 3.61%	71,700 $1.82 Million

Q4 2022 Feb 10, 2023	BUY	$28.0 - $40.56 $36,596 - $53,011	1,307 Added 1.79%	74,388 $3.02 Million
Q3 2022 Nov 09, 2022	BUY	$29.63 - $48.31 $51,082 - $83,286	1,724 Added 2.42%	73,081 $2.42 Million
Q2 2022 Aug 15, 2022	BUY	$27.79 - $50.61 $9,670 - $17,612	348 Added 0.49%	71,357 $2.51 Million
Q1 2022 Jun 30, 2022	SELL	$39.62 - $69.97 $108,717 - $191,997	-2,744 Reduced 3.72%	71,009 $3.27 Million
Q4 2021 Feb 15, 2022	BUY	$58.09 - $82.51 $16,497 - $23,432	284 Added 0.39%	73,753 $4.89 Million
Q3 2021 Oct 29, 2021	SELL	$58.38 - $84.96 $449,292 - $653,852	-7,696 Reduced 9.48%	73,469 $4.59 Million
Q2 2021 Aug 16, 2021	BUY	$62.15 - $90.32 $4.08 Million - $5.93 Million	65,699 Added 424.8%	81,165 $6.72 Million
Q1 2021 May 13, 2021	SELL	$61.35 - $90.47 $68,650 - $101,235	-1,119 Reduced 6.75%	15,466 $1.03 Million
Q4 2020 Feb 12, 2021	BUY	$43.82 - $85.37 $7,011 - $13,659	160 Added 0.97%	16,585 $1.27 Million
Q3 2020 Oct 30, 2020	SELL	$33.21 - $51.27 $17,933 - $27,685	-540 Reduced 3.18%	16,425 $707,000
Q2 2020 Aug 10, 2020	SELL	$26.12 - $43.27 $32,728 - $54,217	-1,253 Reduced 6.88%	16,965 $733,000
Q1 2020 May 13, 2020	BUY	$20.56 - $63.12 $5,633 - $17,294	274 Added 1.53%	18,218 $524,000
Q4 2019 Feb 13, 2020	BUY	$28.14 - $73.01 $15,195 - $39,425	540 Added 3.1%	17,944 $1.14 Million
Q3 2019 Nov 13, 2019	SELL	$26.26 - $34.86 $7,037 - $9,342	-268 Reduced 1.52%	17,404 $490,000
Q2 2019 Aug 14, 2019	BUY	$17.43 - $28.82 $73,694 - $121,850	4,228 Added 31.45%	17,672 $468,000
Q1 2019 May 15, 2019	BUY	$12.05 - $20.18 $7,712 - $12,915	640 Added 5.0%	13,444 $247,000
Q4 2018 Feb 15, 2019	BUY	$10.74 - $19.7 $137,514 - $252,238	12,804 New	12,804 $159,000
Q3 2018 Nov 14, 2018	SELL	$14.0 - $20.3 $185,990 - $269,685	-13,285 Closed	0 $0
Q2 2018 Jul 18, 2018	BUY	$6.37 - $14.02 $84,625 - $186,255	13,285 New	13,285 $181,000

Others Institutions Holding ARWR

# of Institutions

296

Shares Held

88.5M

Call Options Held

905K

Put Options Held

387K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.65B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Arrowhead Pharmaceuticals, Inc. Transaction History